Skip to content
healthcare.dev

Lubiprostone

NDC 65162-842, Lubiprostone, capsule, from Amneal Pharmaceuticals LLC.

Product NDC
65162-842
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209450
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-842 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUBIPROSTONE24 ug/1

Pharmacologic classes

Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]

Package NDCNDC-11Package
65162-842-066516208420660 CAPSULE in 1 BOTTLE (65162-842-06)
65162-842-1865162084218180 CAPSULE in 1 BOTTLE (65162-842-18)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/333acede-5075-464f-9418-4b22d43eef3c

Use it

Look up 65162-842 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-842 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-842. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.